1 Bioengineered Protein Drugs Market Overview 1.1 Product Overview and Scope of Bioengineered Protein Drugs 1.2 Bioengineered Protein Drugs Segment by Type 1.2.1 Global Bioengineered Protein Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Monoclonal Antibodies 1.2.3 Therapeutic Proteins 1.2.4 Vaccines 1.3 Bioengineered Protein Drugs Segment by Application 1.3.1 Global Bioengineered Protein Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Cancer 1.3.3 Diabetes 1.3.4 Autoimmune Disorder 1.3.5 Infectious Disease 1.3.6 Neurodegenerative 1.3.7 Others 1.4 Global Bioengineered Protein Drugs Market Size Estimates and Forecasts 1.4.1 Global Bioengineered Protein Drugs Revenue 2016-2027 1.4.2 Global Bioengineered Protein Drugs Sales 2016-2027 1.4.3 Bioengineered Protein Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 Bioengineered Protein Drugs Market Competition by Manufacturers 2.1 Global Bioengineered Protein Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global Bioengineered Protein Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Bioengineered Protein Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Bioengineered Protein Drugs Manufacturing Sites, Area Served, Product Type 2.5 Bioengineered Protein Drugs Market Competitive Situation and Trends 2.5.1 Bioengineered Protein Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Bioengineered Protein Drugs Players Market Share by Revenue 2.5.3 Global Bioengineered Protein Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Bioengineered Protein Drugs Retrospective Market Scenario by Region 3.1 Global Bioengineered Protein Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Bioengineered Protein Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Bioengineered Protein Drugs Market Facts & Figures by Country 3.3.1 North America Bioengineered Protein Drugs Sales by Country 3.3.2 North America Bioengineered Protein Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Bioengineered Protein Drugs Market Facts & Figures by Country 3.4.1 Europe Bioengineered Protein Drugs Sales by Country 3.4.2 Europe Bioengineered Protein Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Bioengineered Protein Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Bioengineered Protein Drugs Sales by Region 3.5.2 Asia Pacific Bioengineered Protein Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Bioengineered Protein Drugs Market Facts & Figures by Country 3.6.1 Latin America Bioengineered Protein Drugs Sales by Country 3.6.2 Latin America Bioengineered Protein Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Bioengineered Protein Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Bioengineered Protein Drugs Sales by Country 3.7.2 Middle East and Africa Bioengineered Protein Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Bioengineered Protein Drugs Historic Market Analysis by Type 4.1 Global Bioengineered Protein Drugs Sales Market Share by Type (2016-2021) 4.2 Global Bioengineered Protein Drugs Revenue Market Share by Type (2016-2021) 4.3 Global Bioengineered Protein Drugs Price by Type (2016-2021) 5 Global Bioengineered Protein Drugs Historic Market Analysis by Application 5.1 Global Bioengineered Protein Drugs Sales Market Share by Application (2016-2021) 5.2 Global Bioengineered Protein Drugs Revenue Market Share by Application (2016-2021) 5.3 Global Bioengineered Protein Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Dr.Reddy’s 6.1.1 Dr.Reddy’s Corporation Information 6.1.2 Dr.Reddy’s Description and Business Overview 6.1.3 Dr.Reddy’s Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Dr.Reddy’s Bioengineered Protein Drugs Product Portfolio 6.1.5 Dr.Reddy’s Recent Developments/Updates 6.2 Eli Lilly 6.2.1 Eli Lilly Corporation Information 6.2.2 Eli Lilly Description and Business Overview 6.2.3 Eli Lilly Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Eli Lilly Bioengineered Protein Drugs Product Portfolio 6.2.5 Eli Lilly Recent Developments/Updates 6.3 Merck 6.3.1 Merck Corporation Information 6.3.2 Merck Description and Business Overview 6.3.3 Merck Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Merck Bioengineered Protein Drugs Product Portfolio 6.3.5 Merck Recent Developments/Updates 6.4 Reliance Life Sciences 6.4.1 Reliance Life Sciences Corporation Information 6.4.2 Reliance Life Sciences Description and Business Overview 6.4.3 Reliance Life Sciences Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Reliance Life Sciences Bioengineered Protein Drugs Product Portfolio 6.4.5 Reliance Life Sciences Recent Developments/Updates 6.5 Panacea Biotech 6.5.1 Panacea Biotech Corporation Information 6.5.2 Panacea Biotech Description and Business Overview 6.5.3 Panacea Biotech Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Panacea Biotech Bioengineered Protein Drugs Product Portfolio 6.5.5 Panacea Biotech Recent Developments/Updates 6.6 Novartis 6.6.1 Novartis Corporation Information 6.6.2 Novartis Description and Business Overview 6.6.3 Novartis Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Novartis Bioengineered Protein Drugs Product Portfolio 6.6.5 Novartis Recent Developments/Updates 6.7 Fresenius 6.6.1 Fresenius Corporation Information 6.6.2 Fresenius Description and Business Overview 6.6.3 Fresenius Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Fresenius Bioengineered Protein Drugs Product Portfolio 6.7.5 Fresenius Recent Developments/Updates 6.8 Sanofi 6.8.1 Sanofi Corporation Information 6.8.2 Sanofi Description and Business Overview 6.8.3 Sanofi Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Sanofi Bioengineered Protein Drugs Product Portfolio 6.8.5 Sanofi Recent Developments/Updates 6.9 ProBioGen 6.9.1 ProBioGen Corporation Information 6.9.2 ProBioGen Description and Business Overview 6.9.3 ProBioGen Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.9.4 ProBioGen Bioengineered Protein Drugs Product Portfolio 6.9.5 ProBioGen Recent Developments/Updates 6.10 GlaxoSmithKline 6.10.1 GlaxoSmithKline Corporation Information 6.10.2 GlaxoSmithKline Description and Business Overview 6.10.3 GlaxoSmithKline Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.10.4 GlaxoSmithKline Bioengineered Protein Drugs Product Portfolio 6.10.5 GlaxoSmithKline Recent Developments/Updates 6.11 Roche 6.11.1 Roche Corporation Information 6.11.2 Roche Bioengineered Protein Drugs Description and Business Overview 6.11.3 Roche Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Roche Bioengineered Protein Drugs Product Portfolio 6.11.5 Roche Recent Developments/Updates 6.12 Amoytop Biotech 6.12.1 Amoytop Biotech Corporation Information 6.12.2 Amoytop Biotech Bioengineered Protein Drugs Description and Business Overview 6.12.3 Amoytop Biotech Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Amoytop Biotech Bioengineered Protein Drugs Product Portfolio 6.12.5 Amoytop Biotech Recent Developments/Updates 6.13 Shanghai United Cell Biotechnology 6.13.1 Shanghai United Cell Biotechnology Corporation Information 6.13.2 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Description and Business Overview 6.13.3 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product Portfolio 6.13.5 Shanghai United Cell Biotechnology Recent Developments/Updates 6.14 Hualan Bio 6.14.1 Hualan Bio Corporation Information 6.14.2 Hualan Bio Bioengineered Protein Drugs Description and Business Overview 6.14.3 Hualan Bio Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Hualan Bio Bioengineered Protein Drugs Product Portfolio 6.14.5 Hualan Bio Recent Developments/Updates 7 Bioengineered Protein Drugs Manufacturing Cost Analysis 7.1 Bioengineered Protein Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Bioengineered Protein Drugs 7.4 Bioengineered Protein Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Bioengineered Protein Drugs Distributors List 8.3 Bioengineered Protein Drugs Customers 9 Bioengineered Protein Drugs Market Dynamics 9.1 Bioengineered Protein Drugs Industry Trends 9.2 Bioengineered Protein Drugs Growth Drivers 9.3 Bioengineered Protein Drugs Market Challenges 9.4 Bioengineered Protein Drugs Market Restraints 10 Global Market Forecast 10.1 Bioengineered Protein Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Bioengineered Protein Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Bioengineered Protein Drugs by Type (2022-2027) 10.2 Bioengineered Protein Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Bioengineered Protein Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Bioengineered Protein Drugs by Application (2022-2027) 10.3 Bioengineered Protein Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Bioengineered Protein Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Bioengineered Protein Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Bioengineered Protein Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Bioengineered Protein Drugs Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Bioengineered Protein Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Bioengineered Protein Drugs Covered in This Study Table 5. Global Bioengineered Protein Drugs Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Bioengineered Protein Drugs Sales Market Share by Manufacturers (2016-2021) Table 7. Global Bioengineered Protein Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Bioengineered Protein Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Bioengineered Protein Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Bioengineered Protein Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Bioengineered Protein Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Bioengineered Protein Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioengineered Protein Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Bioengineered Protein Drugs Sales by Region (2016-2021) & (K Units) Table 16. Global Bioengineered Protein Drugs Sales Market Share by Region (2016-2021) Table 17. Global Bioengineered Protein Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Bioengineered Protein Drugs Sales by Country (2016-2021) & (K Units) Table 19. North America Bioengineered Protein Drugs Sales Market Share by Country (2016-2021) Table 20. North America Bioengineered Protein Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Bioengineered Protein Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe Bioengineered Protein Drugs Sales by Country (2016-2021) & (K Units) Table 23. Europe Bioengineered Protein Drugs Sales Market Share by Country (2016-2021) Table 24. Europe Bioengineered Protein Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Bioengineered Protein Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Bioengineered Protein Drugs Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Bioengineered Protein Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Bioengineered Protein Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Bioengineered Protein Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America Bioengineered Protein Drugs Sales by Country (2016-2021) & (K Units) Table 31. Latin America Bioengineered Protein Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America Bioengineered Protein Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Bioengineered Protein Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Bioengineered Protein Drugs Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Bioengineered Protein Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Bioengineered Protein Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Bioengineered Protein Drugs Revenue Market Share by Country (2016-2021) Table 38. Global Bioengineered Protein Drugs Sales (K Units) by Type (2016-2021) Table 39. Global Bioengineered Protein Drugs Sales Market Share by Type (2016-2021) Table 40. Global Bioengineered Protein Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global Bioengineered Protein Drugs Revenue Share by Type (2016-2021) Table 42. Global Bioengineered Protein Drugs Price (USD/Unit) by Type (2016-2021) Table 43. Global Bioengineered Protein Drugs Sales (K Units) by Application (2016-2021) Table 44. Global Bioengineered Protein Drugs Sales Market Share by Application (2016-2021) Table 45. Global Bioengineered Protein Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global Bioengineered Protein Drugs Revenue Share by Application (2016-2021) Table 47. Global Bioengineered Protein Drugs Price (USD/Unit) by Application (2016-2021) Table 48. Dr.Reddy’s Corporation Information Table 49. Dr.Reddy’s Description and Business Overview Table 50. Dr.Reddy’s Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Dr.Reddy’s Bioengineered Protein Drugs Product Table 52. Dr.Reddy’s Recent Developments/Updates Table 53. Eli Lilly Corporation Information Table 54. Eli Lilly Description and Business Overview Table 55. Eli Lilly Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Eli Lilly Bioengineered Protein Drugs Product Table 57. Eli Lilly Recent Developments/Updates Table 58. Merck Corporation Information Table 59. Merck Description and Business Overview Table 60. Merck Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Merck Bioengineered Protein Drugs Product Table 62. Merck Recent Developments/Updates Table 63. Reliance Life Sciences Corporation Information Table 64. Reliance Life Sciences Description and Business Overview Table 65. Reliance Life Sciences Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Reliance Life Sciences Bioengineered Protein Drugs Product Table 67. Reliance Life Sciences Recent Developments/Updates Table 68. Panacea Biotech Corporation Information Table 69. Panacea Biotech Description and Business Overview Table 70. Panacea Biotech Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Panacea Biotech Bioengineered Protein Drugs Product Table 72. Panacea Biotech Recent Developments/Updates Table 73. Novartis Corporation Information Table 74. Novartis Description and Business Overview Table 75. Novartis Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Novartis Bioengineered Protein Drugs Product Table 77. Novartis Recent Developments/Updates Table 78. Fresenius Corporation Information Table 79. Fresenius Description and Business Overview Table 80. Fresenius Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Fresenius Bioengineered Protein Drugs Product Table 82. Fresenius Recent Developments/Updates Table 83. Sanofi Corporation Information Table 84. Sanofi Description and Business Overview Table 85. Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Sanofi Bioengineered Protein Drugs Product Table 87. Sanofi Recent Developments/Updates Table 88. ProBioGen Corporation Information Table 89. ProBioGen Description and Business Overview Table 90. ProBioGen Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. ProBioGen Bioengineered Protein Drugs Product Table 92. ProBioGen Recent Developments/Updates Table 93. GlaxoSmithKline Corporation Information Table 94. GlaxoSmithKline Description and Business Overview Table 95. GlaxoSmithKline Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. GlaxoSmithKline Bioengineered Protein Drugs Product Table 97. GlaxoSmithKline Recent Developments/Updates Table 98. Roche Corporation Information Table 99. Roche Description and Business Overview Table 100. Roche Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Roche Bioengineered Protein Drugs Product Table 102. Roche Recent Developments/Updates Table 103. Amoytop Biotech Corporation Information Table 104. Amoytop Biotech Description and Business Overview Table 105. Amoytop Biotech Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. Amoytop Biotech Bioengineered Protein Drugs Product Table 107. Amoytop Biotech Recent Developments/Updates Table 108. Shanghai United Cell Biotechnology Corporation Information Table 109. Shanghai United Cell Biotechnology Description and Business Overview Table 110. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product Table 112. Shanghai United Cell Biotechnology Recent Developments/Updates Table 113. Hualan Bio Corporation Information Table 114. Hualan Bio Description and Business Overview Table 115. Hualan Bio Bioengineered Protein Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Hualan Bio Bioengineered Protein Drugs Product Table 117. Hualan Bio Recent Developments/Updates Table 118. Production Base and Market Concentration Rate of Raw Material Table 119. Key Suppliers of Raw Materials Table 120. Bioengineered Protein Drugs Distributors List Table 121. Bioengineered Protein Drugs Customers List Table 122. Bioengineered Protein Drugs Market Trends Table 123. Bioengineered Protein Drugs Growth Drivers Table 124. Bioengineered Protein Drugs Market Challenges Table 125. Bioengineered Protein Drugs Market Restraints Table 126. Global Bioengineered Protein Drugs Sales Forecast by Type (2022-2027) & (K Units) Table 127. Global Bioengineered Protein Drugs Sales Market Share Forecast by Type (2022-2027) Table 128. Global Bioengineered Protein Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 129. Global Bioengineered Protein Drugs Revenue Market Share Forecast by Type (2022-2027) Table 130. Global Bioengineered Protein Drugs Sales Forecast by Application (2022-2027) & (K Units) Table 131. Global Bioengineered Protein Drugs Sales Market Share Forecast by Application (2022-2027) Table 132. Global Bioengineered Protein Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 133. Global Bioengineered Protein Drugs Revenue Market Share Forecast by Application (2022-2027) Table 134. Global Bioengineered Protein Drugs Sales Forecast by Region (2022-2027) & (K Units) Table 135. Global Bioengineered Protein Drugs Sales Market Share Forecast by Region (2022-2027) Table 136. Global Bioengineered Protein Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 137. Global Bioengineered Protein Drugs Revenue Market Share Forecast by Region (2022-2027) Table 138. Research Programs/Design for This Report Table 139. Key Data Information from Secondary Sources Table 140. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Bioengineered Protein Drugs Figure 2. Global Bioengineered Protein Drugs Market Share by Type in 2020 & 2027 Figure 3. Monoclonal Antibodies Product Picture Figure 4. Therapeutic Proteins Product Picture Figure 5. Vaccines Product Picture Figure 6. Global Bioengineered Protein Drugs Market Share by Application in 2020 & 2027 Figure 7. Cancer Figure 8. Diabetes Figure 9. Autoimmune Disorder Figure 10. Infectious Disease Figure 11. Neurodegenerative Figure 12. Others Figure 13. Global Bioengineered Protein Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Bioengineered Protein Drugs Market Size 2016-2027 (US$ Million) Figure 15. Global Bioengineered Protein Drugs Sales 2016-2027 (K Units) Figure 16. Global Bioengineered Protein Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 17. Bioengineered Protein Drugs Sales Share by Manufacturers in 2020 Figure 18. Global Bioengineered Protein Drugs Revenue Share by Manufacturers in 2020 Figure 19. The Global 5 and 10 Largest Bioengineered Protein Drugs Players: Market Share by Revenue in 2020 Figure 20. Bioengineered Protein Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 21. Global Bioengineered Protein Drugs Sales Market Share by Region (2016-2021) Figure 22. Global Bioengineered Protein Drugs Sales Market Share by Region in 2020 Figure 23. Global Bioengineered Protein Drugs Revenue Market Share by Region (2016-2021) Figure 24. Global Bioengineered Protein Drugs Revenue Market Share by Region in 2020 Figure 25. U.S. Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Canada Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Germany Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. France Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. U.K. Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Italy Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Russia Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. China Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Japan Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. South Korea Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. India Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Australia Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Taiwan Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Indonesia Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Thailand Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Malaysia Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Philippines Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Vietnam Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Mexico Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Brazil Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Argentina Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Turkey Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Saudi Arabia Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. U.A.E Bioengineered Protein Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Sales Market Share of Bioengineered Protein Drugs by Type (2016-2021) Figure 50. Sales Market Share of Bioengineered Protein Drugs by Application (2016-2021) Figure 51. Sales Market Share of Bioengineered Protein Drugs by Application in 2020 Figure 52. Revenue Share of Bioengineered Protein Drugs by Application (2016-2021) Figure 53. Revenue Share of Bioengineered Protein Drugs by Application in 2020 Figure 54. Manufacturing Cost Structure of Bioengineered Protein Drugs Figure 55. Manufacturing Process Analysis of Bioengineered Protein Drugs Figure 56. Bioengineered Protein Drugs Industrial Chain Analysis Figure 57. Channels of Distribution Figure 58. Distributors Profiles Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

Dr.Reddy’s Eli Lilly Merck Reliance Life Sciences Panacea Biotech Novartis Fresenius Sanofi ProBioGen GlaxoSmithKline Roche Amoytop Biotech Shanghai United Cell Biotechnology Hualan Bio